ImmunityBio
IBRX
IBRX
125 hedge funds and large institutions have $390M invested in ImmunityBio in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 62 increasing their positions, 17 reducing their positions, and 27 closing their positions.
Holders
125
Holders Change
-1
Holders Change %
-0.79%
% of All Funds
2.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
26
Increased
62
Reduced
17
Closed
27
Calls
$8.17M
Puts
$19.9M
Net Calls
-$11.7M
Net Calls Change
+$15M
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$79.4M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$59.9M |
| 3 |
3
BlackRock
New York
|
$75.3M |
| 4 |
4
Northern Trust
Chicago,
Illinois
|
$19.3M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$21M |
